Stéphane Bancel is the CEO of Moderna Inc., a leading biotechnology company known for mRNA technology, especially its COVID-19 vaccine. He joined Moderna in October 2011 and has played a crucial role in shaping the company's vision and strategy. Bancel...
Stéphane Bancel is the CEO of Moderna Inc., a leading biotechnology company known for mRNA technology, especially its COVID-19 vaccine. He joined Moderna in October 2011 and has played a crucial role in shaping the company's vision and strategy. Bancel earned an MBA from Harvard Business School and holds a Master’s degree in Management from École Centrale Paris. Before Moderna, he was the CEO of bioMérieux, a French diagnostics company. His leadership has been pivotal in taking Moderna from a startup to a major player in the pharmaceutical industry. He has overseen impressive financial results and significant innovations. In 2023, Bancel's total compensation was about $3.59 million, a reflection of his performance and the company's success. Under his guidance, Moderna expanded its capabilities while also committing to public health initiatives, ensuring that their products reach low- and middle-income countries. Stéphane is dedicated to advancing mRNA medicines and remains focused on innovative healthcare solutions.